NCT00269906
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 1993
Completion: Dec 31, 1995